Article
Pfizer, BioNtech say flu-COVID shot generates strong immune response in trial
Rating:
0.0
Views:
37
Likes:
1
Library:
1
Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a strong immune response against strains of the viruses in an early- to mid-stage trial.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value